By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Opko Health, Inc. 

4400 Biscayne Boulevard

Miami  Florida  33137  U.S.A.
Phone: 305-575-4100 Fax: n/a


Company News
Opko Health (OPK) To Announce First Quarter Operating And Financial Results On May 9, 2016 4/29/2016 10:26:09 AM
Opko Health (OPK) Presents Additional Data On RAYALDEE At National Kidney Foundation Spring Clinical Meetings 2016 4/28/2016 11:22:34 AM
Opko Health (OPK) Release: FDA Accepts Resubmission Of New Drug Application For RAYALDEE 4/28/2016 10:36:44 AM
Opko Health (OPK) Announces Appointment Of James Demarco As Senior Vice President Of Pharmaceutical Sales 4/25/2016 11:00:04 AM
Opko Health (OPK) Presents Additional Data On Rayaldee At ENDO 2016 4/1/2016 9:50:49 AM
Opko Health (OPK) Presents Additional Data On RAYALDEE To Treat Secondary Hyperparathyroidism In Chronic Kidney Disease 3/31/2016 11:22:28 AM
Opko Health (OPK) Falls as the FDA Halts Approval of Rayaldee 3/30/2016 6:19:21 AM
Opko Health (OPK) Announces Executive Appointment 3/28/2016 6:50:56 AM
Opko Health (OPK) 4Kscore Recommended In 2016 European Association Of Urology Prostate Cancer Guidelines 3/16/2016 9:39:31 AM
Opko Health (OPK) Announces Dosing Of First Subject In Phase I Clinical Study Of A Long-Acting Oxyntomodulin For The Treatment Of Obesity And Type II Diabetes 3/16/2016 8:50:48 AM